Business
CalciMedica Set to Join Russell Microcap® Index
LA JOLLA, Calif., July 1, 2024 /PRNewswire/ -- CalciMedica Inc. ("CalciMedica" or the "Company") (Nasdaq: CALC), a clinical-stage biopharmaceutical company
About this update from Calcimedica, Inc.
[{"type":"text","content":"LA JOLLA, Calif., July 1, 2024 /PRNewswire/ -- CalciMedica Inc. (\"CalciMedica\" or the \"Company\") (Nasdaq: CALC), a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium (\"CRAC\") channel inhibition therapies for acute and chronic inflammatory and immunologic illnesses, today announced that the Company is set to join the Russell Microcap® Index at the conclusion of the 2024 Russell U.S. Indexes annual reconstitution, effective at the open of U.S. equity markets on Monday, July 1, 2024, according to preliminary lists of additions posted on Friday, May 24, 2024.\n\n \n \n \n \n \n \n\n \nThe annual Russell U.S. Indexes reconstitution captures the 4,000 largest U.S. stocks as of Tuesday, April 30, 2024, ranking them by total market capitalization. Membership in the Russell Microcap® Index, which remains in place for one year, means automatic inclusion in the appropriate growth and value style indexes. FTSE Russell determines membership for its Russell indexes primarily by objective, market-capitalization rankings and style attributes.\n\"Our inclusion in the Russell index is representative of the growth that the Company has undergone since becoming a publicly traded company in the first quarter of 2023,\" said Rachel Leheny, Ph.D., Chief Executive Officer of CalciMedica. \"I am grateful to all our employees at CalciMedica for their diligent work in pursuit of our goal of delivering much-needed therapies to patients suffering from acute and chronic inflammatory and immunologic illnesses, while continuing to create value for our stockholders.\"\nRussell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. Russell's U.S. indexes serve as the benchmark for about $10.5 trillion in assets as of the close of December 2023. Russell indexes are part of FTSE Russell, a leading global index provider.\nFiona Bassett, Chief Executive Officer of FTSE Russell, an LSEG Business, commented, \"Russell indexes–now in their 40th year–continue to evolve to reflect the dynamic U.S. economy. Annual rebalancing plays a vital role in establishing accurate benchmarks, ensuring they correctly mirror their designated market segments and remain unbiased in terms of size and style.\"\nFor more information on the Russell ...